SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?
Por um escritor misterioso
Descrição
Rapid antidepressant effects associated with ketamine have shifted the landscape for the
![SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?](https://journals.sagepub.com/cms/10.1177/0269881116652578/asset/images/large/10.1177_0269881116652578-fig1.jpeg)
The current state of research on ayahuasca: A systematic review of
![SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrn2153/MediaObjects/41583_2007_Article_BFnrn2153_Fig1_HTML.jpg)
NMDA receptor trafficking in synaptic plasticity and
![SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?](https://upload.wikimedia.org/wikipedia/commons/a/a6/201805_article.png)
評論文章 Review Article: 最新的百科全書、新聞、評論和研究
![SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?](https://d3i71xaburhd42.cloudfront.net/3209c3d7b3a5a04b3ecd48b7fd49a0cde73e41d3/9-Table1-1.png)
PDF] Does mismatch negativity have utility for NMDA receptor drug
![SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41380-021-01121-1/MediaObjects/41380_2021_1121_Fig4_HTML.png)
Molecular mechanisms underlying the antidepressant actions of
![SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrn2153/MediaObjects/41583_2007_Article_BFnrn2153_Fig2_HTML.jpg)
NMDA receptor trafficking in synaptic plasticity and
![SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00213-018-5022-5/MediaObjects/213_2018_5022_Fig3_HTML.png)
N-Methyl D-aspartate receptor subunit signaling in fear extinction
![SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?](https://www.cell.com/cms/attachment/2021783610/2041693352/fx1.jpg)
DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain
![SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?](https://www.researchgate.net/profile/Michael-Berk-2/publication/262112624/figure/fig2/AS:392527749369864@1470597316771/Proposed-sources-of-oxidative-stress-in-schizophrenia-Oxidative-stress-and-the_Q320.jpg)
PDF) Neuroprogression in schizophrenia: Pathways underpinning
de
por adulto (o preço varia de acordo com o tamanho do grupo)